Amlodipine Cost in Wisconsin 2026: Cash Price, Medicaid, Insurance and Compounding Options

What Does Amlodipine Actually Cost in Wisconsin Right Now?

Generic amlodipine is one of the most affordable prescription drugs in Wisconsin. At most retail pharmacies in 2026, the cash price lands around $8 per month for a 30-day supply, and discount programs can push that lower. The Pfizer brand (Norvasc) carries a list price near $80 per month, but very few patients pay that figure.

Amlodipine belongs to the dihydropyridine calcium channel blocker class and received FDA approval for hypertension and angina. The FDA prescribing information confirms the standard adult dosing range of 5 mg to 10 mg once daily, with a starting dose of 2.5 mg in elderly patients or those with hepatic impairment.

Retail Pharmacy Price Comparison Across Wisconsin

Prices vary by pharmacy chain and location. The table below reflects typical 2026 cash prices for 30 tablets of generic amlodipine 5 mg in Wisconsin.

| Pharmacy | Without Discount Card | With GoodRx or Similar Card | |---|---|---| | Walgreens (statewide) | ~$22 | ~$8 | | CVS (statewide) | ~$20 | ~$7 | | Walmart Pharmacy | ~$4 | ~$4 (already low) | | Pick 'n Save / Kroger | ~$12 | ~$6 | | Independent pharmacies | varies | ~$8 |

Walmart's $4 generic list places amlodipine among its maintained $4 Generics program, making it one of the cheapest chronic-disease medications available without any insurance or card. Patients at Walmart may not need a discount card at all.

How Wisconsin Medicaid Covers Amlodipine

Wisconsin Medicaid (ForwardHealth) covers amlodipine for hypertension and angina, but the benefit comes with a prior authorization (PA) requirement. This means a prescriber must submit clinical documentation demonstrating medical necessity before the plan will pay.

The PA process in Wisconsin typically requires the prescribing clinician to confirm the patient's diagnosis (hypertension, ICD-10 I10; or angina, ICD-10 I20.x), current blood pressure readings or symptom history, and that first-line therapy is appropriate. Most PA requests for a well-established generic like amlodipine are approved within one to two business days when documentation is complete.

ForwardHealth enrollees who are approved pay $0 to $3 per fill depending on their specific program (e.g., BadgerCare Plus vs. standard Medicaid). Patients denied on PA grounds have the right to appeal through the Wisconsin Department of Health Services Office of Administrative Hearings within 45 days of the denial notice. The ForwardHealth provider portal contains current PA criteria, which ForwardHealth updates periodically.

One practical note: some managed care organizations (MCOs) that contract with Wisconsin Medicaid, such as Molina Healthcare of Wisconsin or Dean Health Plan, may apply slightly different PA criteria than the fee-for-service ForwardHealth program. Patients should call the member services number on their ForwardHealth card to confirm which MCO, if any, manages their drug benefit.

Which Wisconsin Insurance Plans Cover Amlodipine?

Generic amlodipine sits on Tier 1 of most commercial formularies in Wisconsin, which is the lowest-cost tier for preferred generics. That placement keeps copays low.

Below is a practical breakdown of how major Wisconsin plan types handle amlodipine coverage in 2026.

Wisconsin commercial PPO/HMO plans (e.g., Dean Health Plan, Security Health Plan, Quartz): Generic amlodipine is typically Tier 1, with copays ranging from $0 to $10 per 30-day fill after the deductible phase. Many plans allow 90-day mail-order fills at two times the monthly copay.

Wisconsin ACA marketplace plans: Amlodipine is listed as a Tier 1 essential generic on silver and gold formularies sold through HealthCare.gov. Bronze plan cost-sharing varies: some Bronze plans apply the full deductible to all drugs until the deductible is met, which could mean paying cash price ($8) until that threshold is reached. Patients with cost-sharing reduction (CSR) subsidies on Silver plans often pay $0 to $5 per fill.

Medicare Part D (Wisconsin enrollees): Under the 2025 to 2026 Medicare redesign, generic amlodipine is a Tier 1 or Tier 2 drug on most Wisconsin Part D plans. After the $2,000 annual out-of-pocket cap introduced by the Inflation Reduction Act takes effect in 2025, many seniors pay only small copays for the full year. For a $8/month drug, the cap is largely irrelevant in practice.

Employer self-funded plans (large Wisconsin employers like Epic, American Family Insurance, Oshkosh Corp): These plans follow individual plan design documents. Generic amlodipine is almost always Tier 1 under standard PBM formularies (e.g., Express Scripts, CVS Caremark). Employees should check their Summary of Benefits and Coverage (SBC) or call the pharmacy benefit number.

The American Heart Association notes that adequate blood pressure control is a key modifiable factor in cardiovascular risk reduction, and affordable access to medications like amlodipine directly supports that goal. AHA hypertension guidance describes calcium channel blockers as first-line agents in specific populations, including Black adults and those with comorbid angina.

The Clinical Case for Amlodipine: What the Evidence Shows

Amlodipine's cost-effectiveness is inseparable from its clinical track record. ASCOT-BPLA (Anglo-Scandinavian Cardiac Outcomes Trial, Blood Pressure Lowering Arm), published in The Lancet in 2005, enrolled 19,257 patients with hypertension and at least three cardiovascular risk factors [1]. The amlodipine-based regimen reduced total cardiovascular events and procedures by 16% compared with an atenolol-based regimen (P<0.0001) and cut the rate of fatal and nonfatal stroke by 23% (P<0.0003).

Patients in ASCOT-BPLA assigned to the amlodipine arm (amlodipine 5 to 10 mg plus perindopril 4 to 8 mg as needed) also showed a 13% reduction in all-cause mortality compared with the atenolol arm, a difference that contributed to the trial being stopped early by the independent data safety monitoring board at a median follow-up of 5.5 years [1].

These are not modest numbers. A 16% reduction in cardiovascular events, at a medication cost of roughly $8 per month, represents one of the most favorable risk-to-cost ratios in outpatient medicine.

The JNC 8 panel, writing in JAMA in 2014, recommended thiazide-type diuretics, calcium channel blockers (including amlodipine), ACE inhibitors, or ARBs as first-line antihypertensive drugs for most patients [2]. That guidance placed amlodipine squarely in the standard of care for the roughly 800,000 Wisconsin adults estimated by the CDC to have high blood pressure. CDC hypertension data shows that approximately 47% of U.S. adults have hypertension, a proportion that applies broadly to Wisconsin's adult population of about 4.5 million.

Is Compounded Amlodipine Legal in Wisconsin?

Compounded amlodipine prepared by a licensed 503A pharmacy is legal in Wisconsin. A 503A pharmacy is a state-licensed, patient-specific compounding pharmacy that operates under Section 503A of the Federal Food, Drug, and Cosmetic Act. These pharmacies can prepare amlodipine in non-standard doses (e.g., 2.5 mg for pediatric titration, or 7.5 mg as an intermediate step) or in alternative formulations (oral liquid for patients with swallowing difficulties) when a prescriber documents a valid clinical rationale.

Compounding is not the same as generic substitution. The Wisconsin Pharmacy Examining Board regulates 503A compounders within the state, and the FDA retains oversight for interstate distribution. Compounded amlodipine is not FDA-approved and is not subject to the same manufacturing standards as commercially produced tablets.

When compounding makes clinical sense:

• A patient requires a dose that does not exist commercially (e.g., 3 mg for a child)
• A patient cannot swallow tablets and needs a liquid suspension
• A documented allergy to an excipient in the commercial tablet (lactose, corn starch)

When compounding does not make sense:

• Simply to avoid the commercial generic's $8/month price (commercial generic already provides the same active ingredient at validated purity)
• As a route to bypass insurance PA requirements (compounded drugs are generally not covered by insurance)

Some telehealth and direct-pay clinics in Wisconsin market compounded amlodipine at very low or zero cost bundled into membership fees. Patients considering this path should verify that the compounding pharmacy holds a valid Wisconsin Pharmacy Examining Board license and that the prescribing clinician is licensed in Wisconsin.

The FDA's guidance on compounding clearly distinguishes 503A (patient-specific) from 503B (outsourcing facility) operations. FDA compounding overview explains that 503A pharmacies may not compound copies of commercially available drugs unless there is a documented clinical difference justifying the compounded preparation.

Can Wisconsin Patients Get Amlodipine Through Telehealth?

Yes. Wisconsin law permits telehealth prescribing of amlodipine, which is a Schedule-uncontrolled, non-controlled medication. A Wisconsin-licensed prescriber (MD, DO, NP, or PA) may conduct a synchronous or asynchronous telehealth visit, assess blood pressure history and cardiovascular risk, and issue a valid prescription for amlodipine without an in-person visit.

Wisconsin Act 56 (2015) established broad telehealth prescribing authority, and subsequent DHS guidance has confirmed that chronic disease management, including hypertension, falls well within scope. The prescriber must establish a valid patient-provider relationship, which typically requires reviewing prior medical records, obtaining a health history, and documenting a clinical assessment.

For patients using HealthRX or similar telehealth platforms, the workflow is:

1. Complete an online intake form with blood pressure history, current medications, and medical background.
2. A licensed Wisconsin clinician reviews the intake and may conduct a live video visit if needed.
3. If clinically appropriate, an amlodipine prescription is sent electronically to the patient's Wisconsin pharmacy of choice.
4. Follow-up blood pressure checks (often via home cuff with reported readings) allow dose adjustment from 5 mg to 10 mg if needed.

Telehealth visits for hypertension management can also capture laboratory data (renal function, potassium) that should be checked periodically in patients on antihypertensives. A 2020 study in JAMA Network Open found that telehealth-based hypertension management produced blood pressure reductions comparable to in-person care at 6 months [3].

Amlodipine Discount Programs Available to Wisconsin Residents

Several savings pathways exist for Wisconsin patients paying out of pocket or facing high copays.

GoodRx and similar discount cards: These are not insurance. They negotiate discounted cash prices at participating pharmacies. In Wisconsin, GoodRx consistently quotes amlodipine 5 mg (30 tablets) between $6 and $9 at major chains. These cards cannot be used simultaneously with insurance.

NeedyMeds and RxAssist: These directories list manufacturer patient assistance programs (PAPs). While Pfizer's Norvasc brand is less relevant at $8/month generic pricing, PAPs may help patients who are uninsured and cannot afford even small costs.

Wisconsin SeniorCare: This state program helps Wisconsin residents aged 65 and older with prescription drug costs. SeniorCare charges an annual enrollment fee (currently $30) and caps drug copays at $5 to $15 per prescription. Amlodipine falls within SeniorCare's covered formulary. SeniorCare details are available through the Wisconsin Department of Health Services.

340B pricing: Wisconsin patients who receive care at a federally qualified health center (FQHC) or other 340B-covered entity may access amlodipine at significantly reduced prices through the 340B Drug Pricing Program. The prescribing clinic's pharmacy (or a contract pharmacy) dispenses at 340B cost, which can be below $4/month.

Mark Cuban's Cost Plus Drugs (CostPlusDrugs.com): This online pharmacy, which operates in Wisconsin, lists generic amlodipine at approximately $3 for 30 tablets as of mid-2025. A valid prescription is required. Shipping adds cost, but for patients paying cash, this may represent the lowest available price in the state.

How the Pfizer Norvasc Savings Card Works in Wisconsin

Pfizer offers a savings card for branded Norvasc (amlodipine besylate) through its PfizerRxPathways program. In Wisconsin, the card works as follows:

• Eligible patients with commercial insurance pay as little as $0 per month (up to a maximum monthly benefit set by Pfizer, which has historically been capped at $150/month).
• Patients without insurance may qualify for free Norvasc through the Pfizer Patient Assistance Program if household income falls below 400% of the federal poverty level.
• Medicare, Medicaid, and other federal program enrollees are not eligible for the commercial savings card (federal anti-kickback restrictions apply).

The practical reality: given that generic amlodipine is therapeutically equivalent to Norvasc and costs $8/month or less, most Wisconsin prescribers and pharmacists will steer patients toward the generic. The Norvasc savings card is most relevant for patients who have an unusual formulary situation or a specific clinical reason to use the brand.

Amlodipine Side Effects and Monitoring That Affect Long-Term Cost

Treatment costs extend beyond the medication price itself. Amlodipine's most common adverse effect is peripheral edema (ankle swelling), occurring in 10.8% of patients at 10 mg per day versus 1.8% at 2.5 mg, according to the FDA prescribing label [4]. Dose-dependent edema may prompt additional clinic visits, diuretic add-on therapy, or a switch to a different agent. Those downstream costs should factor into the total economic picture.

Amlodipine has a long half-life of 30 to 50 hours, which means missed doses have a more gradual effect on blood pressure than drugs with shorter half-lives. This pharmacokinetic property supports once-daily dosing and reduces the clinical consequences of occasional adherence lapses, which is a real-world advantage for patients managing multiple medications.

Routine monitoring for most patients on amlodipine includes:

• Blood pressure checks at 4 to 6 weeks after initiation or dose change
• Renal function and electrolytes at baseline and annually (especially if combined with an ACE inhibitor or ARB)
• Symptom review for edema, flushing, and reflex tachycardia

No specialized blood tests are required specifically for amlodipine itself, which keeps monitoring costs modest compared with drugs requiring regular serum level measurement.

Practical Steps for Wisconsin Patients to Minimize Amlodipine Costs in 2026

Cost minimization for any chronic medication requires a short checklist of actions taken at the point of prescription and at each refill.

First, ask the prescriber to write "dispense as written" only if there is a documented clinical reason. For amlodipine, there is almost never such a reason. The generic is bioequivalent. Second, compare prices across at least three pharmacies using GoodRx, NeedyMeds, or Cost Plus Drugs before filling. A 10-minute price check can save $10 to $20 per month, or $120 to $240 annually. Third, request 90-day fills. Most Wisconsin retail and mail-order pharmacies dispense 90-day supplies at a lower per-tablet cost than monthly fills, and most plans allow 90-day fills for chronic medications.

Fourth, if cost remains a barrier despite a discount card, ask the prescriber whether the clinical team can submit a PA for Wisconsin Medicaid if the patient qualifies, or whether a referral to a 340B-eligible clinic is appropriate. A single visit to an FQHC can open access to below-market drug pricing for the duration of care at that site.

For Wisconsin residents with household income at or below 200% of the federal poverty level, the Wisconsin Well Woman Program and other DHS resources may provide a pathway to ForwardHealth enrollment, which would cover amlodipine with PA at minimal or no patient cost.

Patients already enrolled in a Wisconsin Medicare Advantage plan should check the plan's formulary each October during open enrollment. Switching to a plan that places amlodipine on Tier 1 (vs. Tier 2) could save $5 to $15 per month, or $60 to $180 per year, on a single medication.

In ASCOT-BPLA, the number needed to treat (NNT) to prevent one major cardiovascular event over 5.5 years was approximately 33 with an amlodipine-based regimen versus the atenolol-based comparator [1]. At $8/month, a Wisconsin patient spends about $528 over 5.5 years on generic amlodipine. That calculates to a medication cost of approximately $17,424 per cardiovascular event prevented, not counting the cost of the event itself, which the American Heart Association estimates averages over $20 to 000 in direct medical costs for a first hospitalization for stroke or myocardial infarction.